European Archives - Page 563 of 1163 - European Medical Journal

EULAR 2021 Janssen-Sponsored symposium: “To see is to believe? Guidance on using imaging to optimize patient care in psoriatic arthritis”.

This podcast reviews presentations at EULAR focusing on the emerging role of X-ray, ultrasound, and MRI in the management of PsA in the clinical setting.

EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

This episode highlights both the role of the IL-23 pathway in the pathogenesis of PsA and the potential IL-23 inhibitors hold for improving PsA outcomes.

Thyroid Papillary Carcinoma and Hyperthyroidism: A Case Study

Thyroid cancer is the most common malignant endocrine tumour in the world, but it only accounts for 1% of all cancers…

Novel Effective Treatment Approach to Graft-Versus-Host-Disease

Research has demonstrated that the use of dual cytokine blockers can mitigate toxic reactions, including graft-versus-host-disease…

Could a High-Fibre Diet Improve Responses to Cancer Treatment?

New research has revealed that a high-fibre diet has been linked to an increased progression-free survival (PFS) in patients with melanoma…

The 2022 Pharma Forecast

Join Marc and Helena in kicking off the new year with an episode predicting what 2022 has in store for pharma. Listen now!

Interview: Michael Farthing

I think the most common reason why people select a particular career is, firstly, the inspirational figures that you come across that lead you towards it. That was certainly true for me. I had some very remarkable early role models.

Giant Urinary Bladder Stone in a Middle-Aged Male

Approximately 10–15% of the general population is affected by urolithiases at least once in their lifetime. Having a giant urinary bladder stone is a particularly rare condition and its development is usually associated with disorders that promote urinary stasis.

The Medicine of Reflection

Jonathan takes us through his thoughts on 2021’s landmark achievements and follies in the healthcare space, including an overview on COVID-19.

Why EGFR Exon 21 L858R Mutations Should Be Treated Differently

The two most common EGFR mutations differ in their kinase domain structures at different sites, resulting in differential sensitivity to EGFR